Cargando…
42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS
BACKGROUND: Psychotic patients are at high risk for developing obesity, metabolic syndrome and type 2 diabetes. These metabolic co-morbidities are hypothesized to be related to both treatment side-effects as well as to metabolic changes occurring during the psychosis. Earlier metabolomics studies ha...
Autores principales: | Hyötyläinen, Tuulia, Suvitaival, Tommi, Geng, Dawei, Pöhö, Päivi, Mattila, Ismo, Suvisaari, Jaana, Oresic, Matej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887308/ http://dx.doi.org/10.1093/schbul/sby014.176 |
Ejemplares similares
-
Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis
por: Suvitaival, T, et al.
Publicado: (2016) -
Metabolome in schizophrenia and other psychotic disorders: a general population-based study
por: Orešič, Matej, et al.
Publicado: (2011) -
42. METABOLISM AND CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Oresic, Matej
Publicado: (2018) -
Targeted Serum Metabolite Profiling Identifies Metabolic Signatures in Patients with Alzheimer's Disease, Normal Pressure Hydrocephalus and Brain Tumor
por: Orešič, Matej, et al.
Publicado: (2018) -
Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children
por: Madrid-Gambin, Francisco, et al.
Publicado: (2019)